• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

National Institute of Allergy and Infectious Diseases (NIAID)

NIH launches study of allergic reactions to COVID-19 vaccines

April 7, 2021 By Chris Newmarker Leave a Comment

The NIH today announced that a clinical trial is underway to study whether people who are highly allergic or have a mast cell disorder are more likely to develop an allergic reaction to the Moderna or Pfizer-BioNTech COVID-19 vaccines. Reports of severe allergic reactions to COVID-19 vaccines have made headlines since the rollout to the […]

Filed Under: Clinical Trials, Featured, Pharmaceutical Tagged With: BioNTech, coronavirus, COVID-19, COVID-19 vaccine trial, Moderna, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Pfizer

NIAID expresses concern over AstraZeneca’s COVID-19 vaccine data

March 23, 2021 By Sean Whooley

The National Institute of Allergy and Infectious Diseases (NIAID) has announced concerns with data from AstraZeneca’s COVID-19 vaccine trial. NIAID, a wing of the National Institutes of Health (NIH), said in a statement today that it was concerned that information the company released from its AZD1222 vaccine clinical trial may be outdated. In turn, that […]

Filed Under: Clinical Trials, Featured, Pharmaceutical, Regulatory/Compliance Tagged With: AstraZeneca, coronavirus, COVID-19, COVID-19 vaccine, COVID-19 vaccine trial, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)

Abbott researchers help discover a clue to an HIV cure

March 2, 2021 By Chris Newmarker

Abbott announced today that a team including its scientists has uncovered a rare group of Democratic Republic of Congo residents who are HIV positive but have almost nonexistent viral loads without using antiretroviral treatments. This group of “HIV elite controllers” opens up a new area for researchers to discover biological trends that could inform the […]

Filed Under: Featured, Pharmaceutical Tagged With: Abbott, HIV/AIDs, Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID), Université Protestante au Congo, University of Missouri-Kansas City

NIAID halts Lilly COVID-19 antibody study

October 27, 2020 By Nancy Crotti

An arm of NIH has ended a clinical trial investigating the use of Eli Lilly’s (NYSE:LLY) monoclonal antibody LY-CoV555 (bamlanivimab) to treat hospitalized COVID-19 patients. While the drug shows promise in treating mild-to-moderate COVID-19 infections, the ACTIV-3 trial involving severe cases of the disease showed little benefit, according to the National Institute of Allergy and Infectious Diseases […]

Filed Under: Business/Financial News, Clinical Trials Tagged With: coronavirus, COVID-19, Eli Lilly & Co., National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)

What are the top COVID-19 vaccine candidates?

September 25, 2020 By Nancy Crotti

As of yesterday, five COVID-19 vaccine candidates had begun Phase 3 clinical trials as they seek to determine the safety and efficacy of their formulas. Researchers worldwide are testing 132 COVID-19 vaccine candidates, including 42 that are in clinical trials on humans and at least 92 in preclinical or animal trials, according to the New […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Pharmaceutical, Research & Development Tagged With: AstraZeneca plc, BioNTech, coronavirus, COVID-19, GlaxoSmithKline plc, Johnson & Johnson, Moderna, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Pfizer, Sanofi, U.S. Biomedical Advanced Research and Development Authority (BARDA)

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS